TrialFuture oncology (London, England)2020

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with

Tanios S Bekaii-Saab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.